KV Pharmaceutical Shares Plunged: What You Need to Know

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of prescription drug developer KV Pharmaceutical (NYSE: KV-A  ) aren't looking too good today, falling as much as 11.3% on above-average trading volume.

So what: The drop comes as KV announced a significantly reduced price for its recently FDA-approved preterm labor prevention drug, Makena. The drug's high price to patients had come under heavy fire, and this was KV's way out of that quandary.

Now what: The official party line is that KV took action to ensure access to the drug for women at high risk. If you believe that halo-topped vision, I have some oceanfront property set aside for you in Switzerland. The drug would simply not fly under the old pricing plan. Makena remains a potential blockbuster even as a lower-margin product, and KV's stock has still more than tripled since that crucial FDA approval, but it looks like early investors and company brass got a little too greedy for their own good.

Interested in more info on KV Pharmaceutical? Add it to your watchlist.

Fool contributor Anders Bylund holds no position in any of the companies discussed here. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool is investors writing for investors.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1468857, ~/Articles/ArticleHandler.aspx, 10/21/2014 4:40:59 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement